Por favor, use este identificador para citar o enlazar a este item:
http://hdl.handle.net/10261/88949
COMPARTIR / EXPORTAR:
SHARE CORE BASE | |
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE | |
Título: | Neural plasticity and proliferation in the generation of antidepressant effects: Hippocampal implication |
Autor: | Pilar-Cuéllar, Fuencisla CSIC ORCID; Vidal, Rebeca CSIC ORCID; Díaz, Álvaro CSIC ORCID; Castro, Elena CSIC ORCID; Anjos, Severiano dos CSIC; Pascual-Brazo, Jesús CSIC; Linge, Raquel CSIC; Vargas, Verónica Inés CSIC; Blanco, Helena CSIC; Martínez-Villayandre, Beatriz CSIC; Pazos, Ángel CSIC ORCID; Valdizán, Elsa M. CSIC ORCID | Fecha de publicación: | 2013 | Editor: | Hindawi Publishing Corporation | Citación: | Neural Plasticity: 537265 (2013) | Resumen: | It is widely accepted that changes underlying depression and antidepressant-like effects involve not only alterations in the levels of neurotransmitters as monoamines and their receptors in the brain, but also structural and functional changes far beyond. During the last two decades, emerging theories are providing new explanations about the neurobiology of depression and the mechanism of action of antidepressant strategies based on cellular changes at the CNS level. The neurotrophic/plasticity hypothesis of depression, proposed more than a decade ago, is now supported by multiple basic and clinical studies focused on the role of intracellular-signalling cascades that govern neural proliferation and plasticity. Herein, we review the state-of-the-art of the changes in these signalling pathways which appear to underlie both depressive disorders and antidepressant actions. We will especially focus on the hippocampal cellularity and plasticity modulation by serotonin, trophic factors as brain-derived neurotrophic factor (BDNF), and vascular endothelial growth factor (VEGF) through intracellular signalling pathways - cAMP, Wnt/β-catenin, and mTOR. Connecting the classic monoaminergic hypothesis with proliferation/neuroplasticity-related evidence is an appealing and comprehensive attempt for improving our knowledge about the neurobiological events leading to depression and associated to antidepressant therapies. © 2013 Fuencisla Pilar-Cuéllar et al. | Descripción: | This is an open access article distributed under the Creative Commons Attribution License. | Versión del editor: | http://dx.doi.org/10.1155/2013/537265 | URI: | http://hdl.handle.net/10261/88949 | DOI: | 10.1155/2013/537265 | Identificadores: | doi: 10.1155/2013/537265 issn: 2090-5904 e-issn: 1687-5443 |
Aparece en las colecciones: | (IBBTEC) Artículos |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
Neural plasticity.pdf | 2,72 MB | Adobe PDF | Visualizar/Abrir |
CORE Recommender
PubMed Central
Citations
40
checked on 30-mar-2024
SCOPUSTM
Citations
76
checked on 20-abr-2024
WEB OF SCIENCETM
Citations
65
checked on 22-feb-2024
Page view(s)
329
checked on 22-abr-2024
Download(s)
867
checked on 22-abr-2024